Singbao International Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.44%

Singbao International Co Ltd (6130) has an Asset Resilience Ratio of 2.44% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Singbao International Co Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets

NT$22.22 Million
≈ $700.02K USD Cash + Short-term Investments

Total Assets

NT$910.96 Million
≈ $28.70 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Singbao International Co Ltd's Asset Resilience Ratio has changed over time. See 6130 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Singbao International Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Singbao International Co Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$22.22 Million 2.44%
Total Liquid Assets NT$22.22 Million 2.44%

Asset Resilience Insights

  • Limited Liquidity: Singbao International Co Ltd maintains only 2.44% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Singbao International Co Ltd Industry Peers by Asset Resilience Ratio

Compare Singbao International Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 7.18%
CSPC Pharmaceutical Group Limited
F:CVG
Drug Manufacturers - General 4.64%
Aurora Optoelectronics Co Ltd
SHG:600666
Drug Manufacturers - General 5.89%
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281
Drug Manufacturers - General 6.44%
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3
Drug Manufacturers - General 10.10%
Pfizer Inc
NYSE:PFE
Drug Manufacturers - General 7.18%
Merck & Company Inc
NYSE:MRK
Drug Manufacturers - General 14.06%
Firebrick Pharma Ltd
AU:FRE
Drug Manufacturers - General 0.29%

Annual Asset Resilience Ratio for Singbao International Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Singbao International Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.14% NT$20.96 Million
≈ $660.32K
NT$978.41 Million
≈ $30.83 Million
-2.59pp
2023-12-31 4.74% NT$45.79 Million
≈ $1.44 Million
NT$966.90 Million
≈ $30.46 Million
+0.44pp
2022-12-31 4.30% NT$40.37 Million
≈ $1.27 Million
NT$938.96 Million
≈ $29.58 Million
+2.38pp
2021-12-31 1.92% NT$10.55 Million
≈ $332.29K
NT$550.64 Million
≈ $17.35 Million
+0.62pp
2020-12-31 1.30% NT$15.88 Million
≈ $500.34K
NT$1.22 Billion
≈ $38.48 Million
-0.70pp
2019-12-31 2.00% NT$11.22 Million
≈ $353.52K
NT$562.21 Million
≈ $17.71 Million
+0.13pp
2018-12-31 1.86% NT$7.68 Million
≈ $241.93K
NT$412.31 Million
≈ $12.99 Million
-2.18pp
2017-12-31 4.04% NT$17.86 Million
≈ $562.75K
NT$442.18 Million
≈ $13.93 Million
-11.85pp
2016-12-31 15.89% NT$50.00 Million
≈ $1.58 Million
NT$314.67 Million
≈ $9.91 Million
+0.97pp
2015-12-31 14.92% NT$50.00 Million
≈ $1.58 Million
NT$335.07 Million
≈ $10.56 Million
--
pp = percentage points

About Singbao International Co Ltd

TWO:6130 Taiwan Drug Manufacturers - General
Market Cap
$34.05 Million
NT$1.08 Billion TWD
Market Cap Rank
#23283 Global
#1467 in Taiwan
Share Price
NT$24.40
Change (1 day)
-1.81%
52-Week Range
NT$24.05 - NT$47.25
All Time High
NT$66.65
About

Shangya Technology Co., Ltd. engages in the generic drugs and solar power generation businesses in Taiwan and Asia. The company wholesales Chinese and Western medicines, medical equipment, and beauty and hair care products; and onrito, lixin fumitation, lufuxing film-coated, amperex film coating, leverb-coated, triton film-coated, special core stabilized, tanlipo film-coated, inhibitory film-coat… Read more